Viewing Study NCT00114218


Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2026-01-05 @ 10:30 PM
Study NCT ID: NCT00114218
Status: COMPLETED
Last Update Posted: 2019-01-08
First Post: 2005-06-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
Sponsor: Gynecologic Oncology Group
Organization: